SCHEMBL30413419

SCHEMBL30413419

NC(=O)c1cc(O)c(I)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ PARP1 P09874 4/20 0.38
▸ PTPN11 Q06124 2/20 0.38
▸ TTR P02766 1/20 0.38
▸ BCAT2 O15382 1/20 0.38
▸ LCK P06239 1/20 0.37
▸ TPMT P51580 1/20 0.37
▸ CYP3A4 P08684 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA3 P07451 1/20 0.34
▸ CA4 P22748 1/20 0.34
▸ CA6 P23280 1/20 0.34
▸ CA5A P35218 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ CA13 Q8N1Q1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26095202 1.00 LMNA (0.40) LMNAHTTPARP1PTPN11TTR
SCHEMBL26095257 0.82 TTR (0.59) LMNATTRTPMTSMN1; SMN2CA12
SCHEMBL30413369 0.82 TTR (0.59) LMNATTRTPMTSMN1; SMN2CA12
SCHEMBL30311441 0.79 HSD17B10 (0.48) LMNAHTTPARP1PTPN11TTR
SCHEMBL4104322 0.76 TTR (0.62) LMNAHTTPARP1PTPN11TTR
SCHEMBL26091032 0.76 LMNA (0.58) LMNAHTTPTPN11TPMTSMN1; SMN2
SCHEMBL3130004 0.73 LMNA (0.47) LMNAHTTPARP1TTRBCAT2
SCHEMBL811037 0.72 LMNA (0.46) LMNAHTTPARP1TTRBCAT2
SCHEMBL30325618 0.72 HSD11B1 (0.50) LMNAHTTPARP1TTRBCAT2
SCHEMBL1786932 0.71 LCK (0.53) LMNAPARP1BCAT2LCKSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4419532-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. Hoffmann-La Roche AG (CH) 2024-08-28 — — EP disclosed
WO-2023066825-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-04-27 — — WO disclosed
Send feedback